Risk factors for modified vaccine effectiveness of the live attenuated zoster vaccine among the elderly in England()

BACKGROUND: The United Kingdom introduced routine vaccination with the live-attenuated zoster vaccine for 70 year-olds in 2013, with the vaccine also offered to 79 year-olds as part of a catch-up campaign. In the subsequent years, the catch-up campaign was extended to also include adults aged 78 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Bollaerts, Kaatje, Alexandridou, Maria, Verstraeten, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668231/
https://www.ncbi.nlm.nih.gov/pubmed/31384729
http://dx.doi.org/10.1016/j.jvacx.2019.100007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668231/
https://www.ncbi.nlm.nih.gov/pubmed/31384729
http://dx.doi.org/10.1016/j.jvacx.2019.100007

Ejemplares similares